Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1800405-30-4
2. Kl1333
3. Kl-1333
4. Na2zol5ugm
5. 2-(1-methylethyl)-3h-naphth(1,2-d)imidazole-4,5-dione
6. 2-isopropyl-3h-naphtho(1,2-d)imidazole-4,5-dione
7. 3h-naphth(1,2-d)imidazole-4,5-dione, 2-(1-methylethyl)-
8. Nqo1 Activator 1
9. Unii-na2zol5ugm
10. Chembl4594430
11. Schembl16878775
12. Bcp31080
13. Ex-a3108
14. Zb1590
15. Kl 1333;kl-1333
16. Hy-128895
17. Cs-0102150
18. 2-propan-2-yl-3h-benzo[e]benzimidazole-4,5-dione
Molecular Weight | 240.26 g/mol |
---|---|
Molecular Formula | C14H12N2O2 |
XLogP3 | 2.3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 1 |
Exact Mass | 240.089877630 g/mol |
Monoisotopic Mass | 240.089877630 g/mol |
Topological Polar Surface Area | 62.8 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 380 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
71
PharmaCompass offers a list of KL1333 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right KL1333 manufacturer or KL1333 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred KL1333 manufacturer or KL1333 supplier.
PharmaCompass also assists you with knowing the KL1333 API Price utilized in the formulation of products. KL1333 API Price is not always fixed or binding as the KL1333 Price is obtained through a variety of data sources. The KL1333 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A KL1333 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of KL1333, including repackagers and relabelers. The FDA regulates KL1333 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. KL1333 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A KL1333 supplier is an individual or a company that provides KL1333 active pharmaceutical ingredient (API) or KL1333 finished formulations upon request. The KL1333 suppliers may include KL1333 API manufacturers, exporters, distributors and traders.
KL1333 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of KL1333 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right KL1333 GMP manufacturer or KL1333 GMP API supplier for your needs.
A KL1333 CoA (Certificate of Analysis) is a formal document that attests to KL1333's compliance with KL1333 specifications and serves as a tool for batch-level quality control.
KL1333 CoA mostly includes findings from lab analyses of a specific batch. For each KL1333 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
KL1333 may be tested according to a variety of international standards, such as European Pharmacopoeia (KL1333 EP), KL1333 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (KL1333 USP).